Latest OGX Stories

BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 2, 2012 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced financial results for its second quarter and six months ended June 30, 2012 and provided an overview of the clinical development activities of its two product candidates, custirsen and OGX-427. Custirsen Clinical Development Highlights The Company announced detailed plans for the ENSPIRIT trial, an international, randomized Phase 3 study in...

RIO DE JANEIRO, April 4, 2012 /PRNewswire/ -- The EBX Group and IBM (NYSE: IBM) today announced a strategic agreement that includes: IBM's investment in SIX Automacao; the creation at SIX Automacao of a joint center for the development of technology solutions and investments in R&D focused primarily on natural resources and infrastructure; and the outsourcing to IBM of IT operations of EBX Group. (Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO ) As part of the...

RIO DE JANEIRO, March 14, 2012 /PRNewswire/ -- Eike Batista's EBX Group and the Newrest Group, a large player in the international catering market, announce the launch of NRX-NEWREST, a joint venture company. Sebastien Gervais, one of the most experienced executives in the catering sector, has been named CEO of the new company. NRX-NEWREST will act in airline and railway catering, remote site operations, onshore and offshore operational support, cleaning and hospitality sectors...

HOUSTON, Oct. 24, 2011 /PRNewswire/ -- Cameron has elected Rodolfo Landim to the Company's Board of Directors, effective October 18, 2011. Landim, 54, is currently the chief executive officer of YXC Oleo e Gas and Controlling Partner and Managing Director of Mare Investimentos S.A. Prior to that, he was president and chief executive officer of OSX Brazil, chief executive officer of OGX Petroleo e Gas Participacoes S.A., and executive president of MMX Mineracao & Metalicos S.A....

RIO DE JANEIRO, April 18, 2011 /PRNewswire/ -- MPX Energia S.A. ("MPX" or "Company") (Bovespa: MPXE3, GDR I: MPXEY), a Brazilian diversified energy company with the largest portfolio of integrated energy projects in South America, adding up to 11 GW, and complementary businesses in power generation, coal mining, and natural gas E&P, today announced that estimates by DeGolyer & MacNaughton ("D&M") indicate that total gross contingent and risked prospective gas resources of the...

BOTHELL, WA and VANCOUVER, Oct. 21 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's third quarter financial results will be released on Thursday, November 4, 2010, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will discuss the company's third quarter results and provide an update on the business, the recent financing and anticipated use of proceeds to advance the product...

BOTHELL, WA and VANCOUVER, Sept. 7 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, president and chief executive officer of OncoGenex, will present at the Stifel Nicolaus Healthcare Conference on Wednesday, September 15 at 10:20 a.m. EST at the Four Seasons Hotel in Boston, MA. Mr. Cormack will also be presenting at the UBS Global Life Sciences Conference on Wednesday, September 22 at 1:00 p.m. EST at the Grand Hyatt in New York,...

BOTHELL, WA, and VANCOUVER, Aug. 10 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), announced today that the Company has appointed Mr. David V. Smith to its board of directors. Mr. Smith brings to the board substantial financial expertise in financial controls, analytics and process. Having served in executive financial positions for multi-billion dollar life sciences companies, Mr. Smith also adds deep experience in the design and implementation of strategic growth...

Conference Call on Thursday, August 5, 2010 at 4:30 p.m. Eastern Time BOTHELL, WA and VANCOUVER, Aug. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI) today reported unaudited financial results for the three and six months ended June 30, 2010 and reviewed the Company's highlights for the second quarter of 2010. The Company reported net income of $0.2 million for the quarter ended June 30, 2010. Net loss before income taxes for the...

BOTHELL, WA and VANCOUVER, July 29 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter financial results will be released on Thursday, August 5, 2010, and that the Company will host a conference call and live webcast at 4:30 p.m. EDT that afternoon. To access the webcast, log on to the Investor Relations page of the OncoGenex Web site at www.oncogenex.com. Alternatively, you may access the live conference call by dialing...